Replies to post #193914 on Biotech Values

[DewDiligence]

I owned OXGN briefly in 2003-2004, which seems like half a lifetime ago. I cashed out when I determined that OXGN’s CA4P program in AMD was going nowhere—see, for instance, #msg-4843868 and #msg-3373576.

Haven’t followed the company closely in a long time.